Ophthalmic Business News

Ascendis Pharma announced the launch of Eyconis, a company formed with the exclusive rights to develop, manufacture and commercialize Ascendis’ TransCon ophthalmology assets, according to a press release.

In this episode, Cathleen McCabe, MD, Dagny Zhu, MD, and Laura Periman, MD, chat with Kendra Hileman and Jasmine Ainetchian about women in leadership and championing other women in their careers.

You know when you’ve got really good news about something super cool that’s gonna make a lot of your favorite people really happy, and you have to keep it a secret?

In an effort to expand its ophthalmic clinical research services, iuvo BioScience has acquired Promedica International, according to a press release.

Sandoz has signed an agreement to acquire ranibizumab biosimilar Cimerli from Coherus BioSciences, according to a press release.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Lori Tierney, MBA, of Johnson & Johnson Vision, discusses the company’s ongoing projects with Women in Ophthalmology and Ophthalmic World Leaders.

WAILEA, Hawaii — In this Healio video perspective from Hawaiian Eye 2024, Nick Ruth, MBA, of Sydnexis, delivers an update on SYD-101, the company’s upcoming treatment for progressive myopia in pediatric patients.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye/Retina 2024, Rajesh K. Rajpal, MD, chief medical officer at Johnson & Johnson Vision, gives an overview of some the company’s latest innovations in IOLs.

WAILEA, Hawaii —Achieving financial wellness requires a sound understanding of asset allocation and increased “risk tolerance” when investing, according to a presenter at Hawaiian Eye/Retina 2024.

WAILEA, Hawaii — In this Healio video perspective from Hawaiian Eye/Retina 2024, Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals, discusses the phase 2 DAVIO 2 results for EYP-1901 for the treatment of wet AMD.